Lewy body dementia: A progressive form of dementia characterized by the presence of protein deposits called Lewy bodies in the midbrain and cerebral cortex, and loss of cholinergic and dopaminergic neurons. The signs and symptoms overlap with Alzheimer and Parkinson disease.
Other and unspecified degenerative diseases of nervous system
DOID EFO Endpoint Browser PheWeb
G6_DEGENOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
819 |
4. Check minimum number of eventsNone |
819 |
5. Include endpointsNone |
819 |
6. Filter based on genotype QC (FinnGen only) |
819 |
Control definitions (FinnGen only)
- Control exclude
- G6_NEURODEG
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified degenerative diseases of nervous system
based on the number of shared cases.
Similar with more cases:
- Degenerative diseases of the nervous system
- Other degenerative diseases of the nervous system
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10790 | 5168 | 5413 |
| Only index persons | 7351 | 3692 | 3659 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.15 | 0.15 |
| Only index persons | 0.14 | 0.14 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 74.25 | 75.65 | 72.93 |
| Only index persons | 74.27 | 75.65 | 72.88 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 819 | 326 | 493 |
| Unadjusted period prevalence (%) | 0.18 | 0.11 | 0.22 |
| Median age at first event (years) | 72.71 | 72.42 | 72.90 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 722
- Matched controls
- 7218
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
+∞
323.0
413
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
3526.8
280.0
252
*
N06DA03
ATC
rivastigmine; oral, transdermal
30.5
131.7
179
77
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
15.7
99.1
170
139
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
8.4
81.6
198
310
N05AH04
ATC
quetiapine; oral
6.9
80.9
230
455
F03
ICD-10 Finland
Unspecified dementia
10.1
70.1
148
179
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
23.2
68.0
99
49
TAB00
NOMESCO Finland
Lumbar puncture
15.8
61.5
103
75
N05AX08
ATC
risperidone; systemic
7.6
59.4
151
244
G31.0
ICD-10 Finland
Circumscribed brain atrophy
568.4
54.3
53
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
151.4
53.6
56
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
16.2
51.0
84
58
N06DA02
ATC
donepezil; oral
9.8
47.6
100
116
G20
ICD-10 Finland
Parkinson disease
9.0
46.5
103
131
N06DX01
ATC
memantine; oral
8.3
45.4
106
147
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
9.7
44.2
93
108
G30.8
ICD-10 Finland
Other Alzheimer disease
28.5
42.7
58
22
XA800
NOMESCO Finland
Neuropsychological investigation
9.4
36.3
77
90
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.4
34.8
112
237
P20
ICPC
Memory disturbance
3.5
33.7
184
642
AA1AD
NOMESCO Finland
CT of head and brain
2.9
32.9
269
1242
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.2
27.1
111
299
A28
ICPC
Limited function/disability NOS
2.8
27.1
206
890
N05AH03
ATC
olanzapine; systemic
6.8
26.3
68
108
R41.3
ICD-10 Finland
Other amnesia
8.1
26.1
60
80
N99
ICPC
Neurological disease other
18.3
26.0
40
23
3319X
ICD-9 Finland
Other cerebral degenerations, Cerebral degeneration, unspecified
+∞
25.1
24
*
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
+∞
25.1
24
*
R53
ICD-10 Finland
Malaise and fatigue
2.7
25.1
206
926
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
23.4
291
1621
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.5
23.3
87
214
N03AG01
ATC
valproic acid; systemic, rectal
5.3
22.1
70
144
F05.9
ICD-10 Finland
Delirium, unspecified
8.1
21.6
49
64
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
13.4
21.4
37
29
F0280, G318
ICD-10 Finland
NA
+∞
20.9
20
*
N03AE01
ATC
clonazepam; systemic
4.6
20.8
75
178
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
20.7
195
933
G30.0
ICD-10 Finland
Alzheimer disease with early onset
215.9
20.7
21
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
49.5
20.3
24
5
N06AX11
ATC
mirtazapine; oral
2.3
20.2
245
1326
SPAT1216
SPAT
Assessment of functional ability
2.5
20.2
183
856
F06.7
ICD-10 Finland
Mild cognitive disorder
6.7
19.8
51
81
N05BA04
ATC
oxazepam; oral
2.3
19.6
214
1097
P70
ICPC
Dementia
8.9
18.9
40
47
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
+∞
18.8
18
*
L28
ICPC
Limited function/disability (L)
2.5
18.7
174
819
N87
ICPC
Parkinsonism
9.1
18.1
38
44
R41.0
ICD-10 Finland
Disorientation, unspecified
4.6
17.9
63
146
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.9
17.6
75
208
R27.0
ICD-10 Finland
Ataxia, unspecified
21.5
17.4
25
12
N28
ICPC
Limited function/disability (N)
10.1
17.3
34
35
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
17.3
76
217
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
11.1
17.1
32
30
N29
ICPC
Neurological sympt/complt other
7.4
16.8
40
57
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
36.0
16.7
21
6
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
9.3
16.6
34
38
N05BA06
ATC
lorazepam; systemic, sublingual
3.8
16.2
70
197
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
16.0
256
1533
N05AD03
ATC
melperone; systemic
8.8
15.1
32
38
A06AD11
ATC
lactulose; oral
2.2
14.9
169
869
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.1
14.7
85
300
F0289, G318
ICD-10 Finland
NA
+∞
14.6
14
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
14.4
78
262
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.3
14.1
74
243
SPAT1229
SPAT
Assessment of need for aid
2.8
13.7
91
350
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
13.6
13
*
F0029, G308
ICD-10 Finland
NA
+∞
13.6
13
*
F0019, G301
ICD-10 Finland
NA
+∞
13.6
13
*
3318X
ICD-9 Finland
Other cerebral degenerations, Other cerebral degeneration
+∞
13.6
13
*
N05AD01
ATC
haloperidol; systemic
4.3
13.3
49
119
N06AB10
ATC
escitalopram; oral
2.4
13.3
122
562
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.6
13.0
33
52
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
28.9
13.0
17
6
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
50.9
12.9
15
*
S06.0
ICD-10 Finland
Concussion
2.7
12.7
92
372
N06AB04
ATC
citalopram; systemic
2.1
12.5
163
882
I95.1
ICD-10 Finland
Orthostatic hypotension
3.6
12.5
56
163
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
7.6
12.3
28
38
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.5
11.9
56
170
R44.1
ICD-10 Finland
Visual hallucinations
15.0
11.8
19
13
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.3
11.8
43
104
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.9
11.8
38
81
R1250
NOMESCO Finland
Evaluation of functional capability
5.5
11.5
33
62
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
11.3
63
1321
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
11.2
50
145
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.2
11.2
34
68
R25.1
ICD-10 Finland
Tremor, unspecified
4.3
11.0
40
97
SPAT1053
SPAT
Memory test
2.0
10.9
150
828
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.1
10.7
58
196
G93.4
ICD-10 Finland
Encephalopathy, unspecified
60.9
10.6
12
*
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
60.9
10.6
12
*
N06DA04
ATC
galantamine; oral
7.2
10.6
25
36
G32.0*E53.8
ICD-10 Finland
Subacute combined degeneration of the spinal cord in case of vitamin B12 deficiency
+∞
10.4
10
*
F0282, G318
ICD-10 Finland
NA
+∞
10.4
10
*
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
16.3
10.4
16
10
A04
ICPC
Weakness/tiredness general
2.2
10.3
110
541
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
9.8
10.3
20
21
N04BD01
ATC
selegiline; oral
5.5
10.2
29
54
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.7
10.2
70
273
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.1
10.1
24
35
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
10.0
52
171
M03BX01
ATC
baclofen; systemic
6.4
9.9
25
40
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.1
9.9
37
93
N05AX12
ATC
aripiprazole; systemic
6.7
9.5
23
35
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
101.3
9.4
10
*
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
101.3
9.4
10
*
F009, G309
ICD-10 Finland
NA
+∞
9.4
9
*
F06.0
ICD-10 Finland
Organic hallucinosis
22.0
9.4
13
6
N19
ICPC
Speech disorder
7.1
9.4
22
32
K59.09
ICD-10 Finland
Constipation, unspecified
2.8
9.2
59
224
N03AX14
ATC
levetiracetam; systemic
4.7
9.0
29
63
SPAT1234
SPAT
Support of social functional capacity
2.7
8.7
60
237
R47.1
ICD-10 Finland
Dysarthria and anarthria
9.1
8.6
17
19
Z75.5
ICD-10 Finland
Holiday relief care
6.5
8.5
21
33
F01.9
ICD-10 Finland
Vascular dementia, unspecified
4.3
8.5
30
72
G32
ICD-10 Finland
Other degenerative disorders of nervous system in diseases classified elsewhere
+∞
8.3
8
*
F02.8
ICD-10 Finland
Dementia in other specified diseases classified elsewhere
+∞
8.3
8
*
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
+∞
8.3
8
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
8.2
83
400
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
8.2
59
240
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.1
8.1
30
75
N06AX16
ATC
venlafaxine; oral
2.3
8.1
73
333
F00
ICD-10 Finland
Dementia in Alzheimer disease
33.7
8.1
10
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
17.4
8.1
12
7
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
6.0
8.0
21
36
R42
ICD-10 Finland
Dizziness and giddiness
1.7
8.0
175
1122
R4130
NOMESCO Finland
Speech therapy
4.3
7.8
27
64
G11.2
ICD-10 Finland
Late-onset cerebellar ataxia
45.4
7.7
9
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
7.6
133
791
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.9
7.6
45
163
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
7.5
36
113
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
7.5
120
693
R35
ICD-10 Finland
Polyuria
2.4
7.4
61
267
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.3
7.4
66
300
N04BC05
ATC
pramipexole; oral
2.3
7.4
66
301
N05BA01
ATC
diazepam; systemic, rectal
1.9
7.4
104
576
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
7.4
7.2
16
22
R26.0
ICD-10 Finland
Ataxic gait
20.2
7.1
10
5
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
4.6
7.1
23
51
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
10.2
7.0
13
13
S01.0
ICD-10 Finland
Open wound of scalp
2.2
7.0
71
343
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
7.0
115
671
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
7.0
134
821
Z31.5
ICD-10 Finland
Genetic counselling
3.9
6.9
27
72
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
7.6
6.9
15
20
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.9
6.9
21
44
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
16.9
6.8
10
6
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
16.9
6.8
10
6
F22.0
ICD-10 Finland
Delusional disorder
6.5
6.7
16
25
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.7
6.6
21
46
G30
ICD-10 Finland
Alzheimer disease
12.4
6.6
11
9
N06AB06
ATC
sertraline; oral
2.3
6.6
60
274
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.9
6.5
15
22
R51.80
ICD-10 Finland
Headache
2.0
6.5
80
419
N04AA02
ATC
biperiden; systemic
5.1
6.5
19
38
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
70.4
6.4
7
*
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
70.4
6.4
7
*
R5110
SPAT
NA
3.9
6.3
24
63
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
11.1
6.3
11
10
F07.0
ICD-10 Finland
Organic personality disorder
+∞
6.3
6
*
F02.82
ICD-10 Finland
Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations
+∞
6.3
6
*
G93.8
ICD-10 Finland
Other specified disorders of brain
+∞
6.3
6
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
6.3
6
*
F028, G318
ICD-10 Finland
NA
+∞
6.3
6
*
G31
ICD-10 Finland
Other degenerative diseases of nervous system, not elsewhere classified
+∞
6.3
6
*
D21
ICPC
Swallowing problem
5.1
6.2
18
36
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.2
87
481
N05CD07
ATC
temazepam; oral
1.8
6.2
116
706
N06AX26
ATC
vortioxetine; oral
3.1
6.2
32
108
N05AB03
ATC
perphenazine; systemic, rectal
3.3
6.1
28
86
SPAT1254
SPAT
Administration of medicine
1.7
6.1
120
741
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.4
6.1
20
46
P29
ICPC
Psychological sympt/compl other
3.2
6.0
29
93
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
69
28
26.82
98.96
1.1
1.0
ng/l
317.3
199.6
2.75
55
14
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
69
28
26.82
98.96
1.1
1.1
ng/l
41.3
30.6
0.95
55
13
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
69
28
26.82
98.96
1.1
1.0
ng/l
729.4
665.3
0.27
52
15
(3044290) Cell count panel - Cerebral spinal fluid
85
80
11.74
79.73
1.3
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
88
93
10.48
76.14
1.2
1.2
mmol/l
3.9
3.7
0.64
83
86
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
83
101
9.03
64.39
1.4
1.3
e6/l
3.5
38.9
0.63
66
83
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
82
101
8.91
62.99
1.4
1.4
e6/l
307.7
1145.2
0.38
65
85
(3023410) Appearance of Cerebral spinal fluid
43
43
10.50
38.32
1.4
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
42
45
9.78
35.61
1.2
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
40
42
9.96
34.40
1.2
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
37
40
9.64
31.12
1.4
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
281
1445
2.44
29.93
1.9
1.8
nmol/l
1118.2
1176.0
0.44
219
1078
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
38
47
8.43
28.82
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
33
34
10.07
28.71
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
25
11.13
25.22
1.2
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
23
11.18
23.42
1.2
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
26
27
9.91
22.43
1.3
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
23
21
11.24
21.63
1.4
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
36
63
5.93
19.92
5.0
4.2
umol/l
310.5
343.5
0.67
28
55
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
324
2023
2.00
19.43
2.8
2.1
u/l
276.7
255.4
0.12
305
1897
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
21
9.74
17.05
1.2
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
15
10.86
14.68
1.2
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
395
2844
1.75
13.67
2.4
2.1
pmol/l
89.4
93.1
0.85
222
1465
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
17
9.58
13.47
1.2
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
17
9.58
13.47
1.1
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
17
9.58
13.47
1.2
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
17
20
8.66
13.29
1.1
1.3
—
—
—
0
0
(4027681)
18
24
7.65
12.74
1.4
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
203
1220
1.88
12.70
2.0
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
16
9.53
12.58
1.2
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
15
16
9.53
12.58
1.2
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
38
5.92
12.32
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
19
30
6.46
11.59
1.1
1.1
nmol/l
138.3
130.7
0.22
19
30
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
11
11.06
11.08
1.1
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
97
479
2.16
10.42
2.2
1.7
%
1.7
1.6
0.35
81
392
(3026008) Bacteria identified in Urine by Culture
296
2122
1.62
9.41
4.4
3.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
144
850
1.84
9.29
1.9
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
86
424
2.15
9.27
1.8
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
16
27
6.02
9.15
1.2
1.0
u/l
1.1
1.1
—
6
16
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
143
851
1.82
8.97
1.9
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
42
157
2.77
8.27
2.6
2.8
umol/l
27.4
36.8
1.87
35
125
(3023368) Bacteria identified in Blood by Culture
287
2098
1.57
8.15
4.7
4.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
95
1633
0.53
8.01
3.0
3.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
9
13.51
7.40
1.1
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
5
20.22
7.14
1.1
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
211
1486
1.57
6.87
1.7
1.8
pmol/l
457.1
4726801.0
0.50
171
1206
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
6
16.85
6.75
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
28
5.07
6.72
1.1
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
381
3053
1.46
6.60
4.7
6.2
mmol/l
1.2
1.2
1.40
344
2754
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
414
3371
1.46
6.59
5.6
6.9
mmol/l
1.2
1.2
1.14
357
2832
(3031040) Bacteria [#/volume] in Urine by Automated count
497
4192
1.47
6.59
7.2
4.9
e6/l
46.5
2235.7
—
8
80
(3015377) Calcium [Moles/volume] in Serum or Plasma
292
2233
1.48
6.37
2.7
3.6
mmol/l
2.3
2.3
0.05
241
1917
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
8
12.63
6.09
1.0
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
365
2936
1.44
6.02
4.2
4.9
g/l
34.7
34.4
0.41
327
2716
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
40
4.06
5.92
2.5
2.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
96
1525
0.58
5.91
1.4
1.6
mmol/l
1.3
1.3
0.32
84
1240
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
60
3.39
5.75
1.2
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
19
57
3.39
5.47
1.2
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
185
1326
1.51
5.42
2.9
3.2
mmol/l
2.5
2.5
0.06
160
1153
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
5
16.14
5.42
1.0
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
231
1741
1.46
5.25
1.7
1.6
nmol/l
19.7
20.5
0.33
205
1439
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
7
11.52
4.79
1.1
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
514
5740
0.72
4.77
4.8
5.3
mmol/l
2.5
2.5
0.10
439
5143
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
498
5588
0.72
4.74
4.2
4.7
mmol/l
4.4
4.4
0.03
426
5041
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
80
489
1.70
4.54
2.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
181
2382
0.69
4.54
2.0
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
486
5459
0.73
4.52
19.6
16.7
ml/min/173m2
77.8
72.5
6.03
395
4552
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
495
5529
0.74
4.31
4.2
4.7
mmol/l
1.5
1.4
0.69
426
4942
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
7
10.07
4.01
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
294
2399
1.35
4.01
2.4
2.2
nmol/l
75.1
79.3
1.55
246
2083
(3037467) Urinalysis macro (dipstick) panel - Urine
482
4235
1.34
3.96
6.1
4.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
38
193
2.02
3.88
1.2
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
50
282
1.82
3.77
2.0
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
252
0.31
3.77
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
34
169
2.06
3.69
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
34
169
2.06
3.69
1.4
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
126
1713
0.69
3.66
2.4
2.9
umol/l
4053.0
8073.4
0.51
100
1439
(3014271) Vancomycin [Susceptibility]
17
63
2.73
3.50
2.6
2.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
483
5351
0.76
3.49
3.8
4.2
mmol/l
1.2
1.3
1.76
410
4751
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
515
5654
0.76
3.46
4.9
5.0
mmol/l
6.2
6.1
0.50
445
5031
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
10
7.05
3.37
2.0
2.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
10
7.05
3.37
1.7
2.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
14
5.76
3.34
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
179
1386
1.37
3.34
4.9
4.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
7
8.62
3.26
1.2
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
142
1065
1.40
3.20
1.3
1.2
u/ml
0.7
1.7
1.91
35
265
(3018418) pH of Serum or Plasma
245
2008
1.31
3.11
3.5
3.8
ph
7.4
7.4
0.07
32
380
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
820
0.61
3.04
1.2
1.3
u/ml
12.2
12.1
0.01
17
288
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
223
1825
1.30
2.83
2.1
2.2
mg/l
2.9
3.2
1.00
180
1519
(3022145) Colonoscopy Study observation
40
660
0.59
2.81
1.4
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
6
8.37
2.75
1.2
1.0
—
—
—
0
0
(3019225) pH of Specimen
94
674
1.45
2.72
4.4
4.7
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
429
3839
1.25
2.53
6.8
5.0
mmol/l
6.9
6.8
0.14
401
3617
(3005719) IgG [Mass/volume] in Serum or Plasma
62
417
1.53
2.47
2.4
2.6
g/l
10.4
11.1
0.52
54
378
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
312
1.61
2.47
2.1
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
117
1.99
2.42
1.3
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
43
267
1.64
2.40
2.4
2.2
ug/l
359.4
617.8
0.46
37
254
(3004588) Protein electrophoresis panel - Serum or Plasma
74
522
1.46
2.36
1.5
2.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
124
1577
0.75
2.32
3.3
3.4
ug/l
0.7
0.8
1.22
91
1117
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
9
5.58
2.21
1.4
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
9
5.58
2.21
1.4
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
509
5477
0.81
2.15
6.8
6.5
mmol/mol
41.2
41.1
0.05
446
4968
(3019150) Specific gravity of Urine by Refractometry
160
1302
1.28
2.09
5.7
4.5
kg/l
1.0
1.0
0.10
30
190
(40768800) Prostate Pathology biopsy report
8
190
0.42
2.07
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
287
2500
1.23
2.07
3.9
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
106
816
1.34
2.06
11.2
8.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
26
3.10
2.01
1.0
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
134
1073
1.30
1.98
3.0
3.2
mmol/l
0.8
0.8
0.44
121
1000
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
84
629
1.37
1.95
2.1
2.2
g/l
0.2
0.2
0.20
73
583
(44790048)
14
65
2.17
1.89
1.8
1.4
—
—
—
0
0
(44806118)
14
65
2.17
1.89
1.8
1.4
—
—
—
0
0
(44790047)
14
65
2.17
1.89
1.8
1.4
—
—
—
0
0
(44790049)
14
65
2.17
1.89
1.8
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
140
1135
1.28
1.88
3.6
3.2
e6/l
2.3
2.0
0.16
74
643
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
63
861
0.71
1.88
1.2
1.3
iu/ml
16.4
37.3
3.08
16
258
(3020630) Protein [Mass/volume] in Serum or Plasma
84
636
1.36
1.83
1.4
2.8
g/l
65.9
65.9
0.01
72
570
(3020961) Endomysium IgA Ab [Titer] in Serum
34
216
1.60
1.79
1.0
1.1
titre
—
28.5
—
0
6
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
146
1201
1.26
1.75
3.5
3.0
e6/l
1.3
1.1
0.30
81
704
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
58
790
0.71
1.71
3.4
4.0
ug/l
46.1
30.9
0.17
50
677
(3051593) INR in Capillary blood by Coagulation assay
10
42
2.40
1.68
6.7
15.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
42
2.40
1.68
4.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
213
1.57
1.65
3.3
4.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
122
990
1.27
1.64
1.5
1.3
g/l
2.7
2.6
0.07
60
560
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
461
4264
1.19
1.64
4.0
3.7
pmol/l
15.4
15.0
2.16
410
3758
(3000963) Hemoglobin [Mass/volume] in Blood
601
6303
0.83
1.63
30.9
25.9
g/l
130.6
132.5
2.43
586
6181
(3010813) Leukocytes [#/volume] in Blood
601
6303
0.83
1.63
30.8
25.8
e9/l
7.0
6.9
0.09
580
6086
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
14
3.59
1.61
1.6
1.0
miu/ml
1561.8
1724.4
—
5
14
(3026361) Erythrocytes [#/volume] in Blood
601
6301
0.83
1.61
30.7
25.8
e12/l
4.3
4.4
2.53
581
6086
(3009343) pH of Capillary blood
64
475
1.38
1.60
2.9
4.1
ph
7.4
7.4
—
9
54
(3007461) Platelets [#/volume] in Blood
601
6300
0.83
1.60
30.8
25.8
e9/l
239.9
238.0
0.29
584
6112
(3024731) MCV [Entitic volume]
601
6300
0.83
1.60
30.7
25.7
fl
91.8
91.8
0.03
587
6177
(3035941) MCH [Entitic mass]
601
6300
0.83
1.60
30.6
25.7
pg
30.5
30.4
0.22
587
6176
(46235355) HIV 1 and 2 tests - Meaningful Use set
76
580
1.34
1.60
1.4
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
14
70
2.02
1.60
1.4
1.4
mosm/kgh2o
270.2
275.2
—
9
45
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
152
1.67
1.58
1.5
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
330
2974
1.18
1.57
9.0
11.7
inr
1.3
1.4
0.29
75
790
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
61
453
1.37
1.53
3.0
4.1
mmol/l
1.1
2.0
0.83
49
338
(3021589) Normoblasts [#/volume] in Blood
230
2608
0.84
1.52
11.1
10.1
e9/l
0.0
0.0
1.09
176
2103
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
27
2.61
1.51
2.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
27
2.61
1.51
1.4
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
49
351
1.42
1.51
2.8
3.4
mmol/l
24.0
24.2
0.20
44
319
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
21
2.87
1.50
1.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
21
2.87
1.50
1.2
2.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
582
6108
0.84
1.50
10.9
11.2
u/l
22.8
24.9
2.68
548
5852
(3027945) Reticulocytes/100 erythrocytes in Blood
111
901
1.27
1.50
1.6
2.3
%
2.0
1.8
0.68
95
798
(3022217) INR in Platelet poor plasma by Coagulation assay
129
1066
1.25
1.50
31.2
28.6
inr
1.3
1.4
0.40
12
141
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
116
1.74
1.50
1.6
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
186
2147
0.83
1.49
4.1
3.9
mg/mmol
7.4
9.7
0.47
113
1382
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
228
2000
1.19
1.47
2.6
2.6
u/l
53.1
57.2
1.33
201
1850
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
64
484
1.35
1.44
3.0
4.1
kpa
5.1
5.2
0.12
58
448
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
211
1844
1.19
1.41
4.0
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
223
1.50
1.38
1.5
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
162
0.49
1.37
1.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
159
1.59
1.36
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
74
578
1.31
1.35
4.5
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
64
825
0.76
1.35
1.2
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
69
535
1.32
1.33
1.9
1.7
—
—
—
0
0
(3000492) Spirometry study
33
473
0.68
1.33
1.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
281
0.60
1.31
1.6
2.4
u/ml
0.3
0.4
—
9
165
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
299
2709
1.16
1.29
4.5
4.3
ng/l
28.3
47.6
4.13
238
2115
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
18
2.79
1.28
1.0
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
88
709
1.27
1.28
2.3
2.5
ug/l
7.2
5.5
0.47
61
611
(40760892) CBC W Ordered Manual Differential panel - Blood
97
1178
0.80
1.28
3.9
4.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
229
0.56
1.27
1.2
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
116
0.43
1.26
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
189
0.52
1.23
1.7
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
19
2.64
1.21
1.6
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
281
1.41
1.20
1.6
2.4
g/l
3.1
3.2
0.33
26
219
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
249
2759
0.86
1.20
4.9
5.6
ug/l
3.0
5.5
0.87
214
2428
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
249
0.59
1.19
1.8
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
159
1378
1.19
1.17
4.1
4.0
ng/l
308.1
263.7
0.09
139
1200
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
215
2404
0.86
1.17
2.6
3.2
ng/l
1247.2
2041.5
4.34
181
2098
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
23
343
0.66
1.16
2.4
1.8
ug/l
4.6
2.2
0.29
18
291
(3014111) Lactate [Moles/volume] in Serum or Plasma
78
631
1.26
1.12
3.3
7.2
mmol/l
1.4
1.4
0.04
71
604
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
375
3483
1.14
1.11
4.1
3.2
u/l
53.6
56.1
0.20
334
3179
(4094501)
7
136
0.51
1.10
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
179
2017
0.86
1.07
3.3
3.2
mg/l
946.8
243.2
0.56
106
1321
(3009508) Creatinine [Moles/volume] in Urine
182
2047
0.86
1.06
3.2
3.1
mmol/l
6.8
7.2
0.64
143
1670
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
15
240
0.62
1.05
1.5
3.1
u/ml
47.0
52.9
0.07
15
232
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
178
0.56
1.04
3.1
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
221
1.42
1.04
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
236
2132
1.15
1.04
4.1
3.4
e6/l
56.5
94.5
0.53
176
1686
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
22
2.28
1.03
3.0
3.5
umol/l
24.2
34.2
—
5
17
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
114
1.59
1.03
1.7
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
34
2.07
1.03
2.9
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
91
1.66
1.01
1.4
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
200
2220
0.87
0.97
4.7
4.8
%
20.1
21.6
0.78
100
1172
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
100
1.61
0.97
1.2
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
85
708
1.22
0.96
3.1
3.5
mmol/l
2.0
2.2
0.21
72
552
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
85
709
1.22
0.95
2.2
3.0
ng/l
151.3
276.4
4.77
79
653
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
3.4
—
116.4
—
0
32
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
144
0.55
0.94
1.5
2.2
%
243.9
203.2
—
8
138
(40761511) CBC panel - Blood by Automated count
574
5956
0.88
0.93
20.2
17.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
27
2.23
0.93
2.8
2.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
80
667
1.22
0.91
1.7
2.5
e9/l
72.4
67.1
0.57
66
522
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
280
1.34
0.90
1.6
2.5
g/l
10.0
10.8
0.43
26
236
(42870588) Differential panel, method unspecified - Blood
226
2056
1.14
0.89
4.5
5.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
300
1.31
0.86
1.6
2.4
g/l
4.1
3.7
0.61
25
215
(3025159) Blasts/100 leukocytes in Blood
35
456
0.76
0.85
4.0
3.9
%
0.0
0.1
—
9
130
(3030467) Casts [#/volume] in Urine by Automated count
214
1946
1.13
0.85
4.1
3.3
e6/l
0.4
0.6
1.34
159
1511
(3020891) Body temperature
38
292
1.32
0.84
4.3
4.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
45
1.79
0.84
2.4
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
301
1.31
0.84
1.6
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
301
1.31
0.84
1.6
2.4
g/l
7.4
7.6
0.18
25
222
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
503
4810
1.12
0.83
6.6
7.7
u/l
78.5
81.5
0.98
460
4483
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
300
2790
1.12
0.82
2.6
2.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
105
1.53
0.82
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
155
1.43
0.81
1.5
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
62
510
1.23
0.81
4.1
5.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
89
1.58
0.81
1.9
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
407
4289
0.90
0.81
4.3
4.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
165
1480
1.14
0.81
6.1
6.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
442
4635
0.90
0.80
25.0
21.3
%
13.7
14.0
3.33
428
4528
(4010399)
32
417
0.76
0.79
1.8
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
24
0.00
0.79
0.0
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(4062490)
8
48
1.67
0.79
1.4
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
90
1.57
0.78
1.4
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
321
3004
1.11
0.78
5.0
5.4
e9/l
1.6
1.9
2.65
263
2608
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
515
0.79
0.77
1.5
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
41
514
0.79
0.76
3.6
3.8
%
1.1
0.9
0.30
12
166
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.7
—
0.9
—
0
28
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
2.9
—
213.3
—
0
28
(36660697) Celiac disease serology panel - Serum
46
369
1.26
0.76
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
313
2929
1.11
0.76
5.0
4.0
estimate
0.0
0.0
0.00
41
556
(3016879) Cocaine [Presence] in Urine
10
59
1.70
0.76
2.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
91
1.55
0.75
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
91
1.55
0.75
1.4
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
75
1.61
0.75
2.0
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
24
2.09
0.74
1.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
184
0.65
0.74
1.6
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
89
767
1.18
0.74
1.9
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
133
0.60
0.74
1.0
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
314
2943
1.11
0.73
4.9
5.2
e9/l
0.6
0.6
1.04
255
2490
(3013115) Eosinophils [#/volume] in Blood
325
3052
1.11
0.73
5.0
5.4
e9/l
0.2
0.2
1.13
269
2643
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
39
488
0.79
0.72
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
92
1.53
0.72
1.4
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
76
1.59
0.72
1.6
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
291
2720
1.11
0.72
5.2
5.4
%
0.6
0.6
1.37
259
2505
(3006315) Basophils [#/volume] in Blood
315
2957
1.11
0.71
4.9
5.2
e9/l
0.0
0.0
0.33
260
2512
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
177
1.37
0.71
2.0
1.5
ug/g
173.3
270.2
1.19
12
100
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
160
1.39
0.71
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
126
1.44
0.70
1.1
1.1
—
9.6
—
0
9
(3003458) Phosphate [Moles/volume] in Serum or Plasma
107
941
1.16
0.70
4.0
5.4
mmol/l
1.0
1.0
0.59
101
868
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
275
2940
0.90
0.70
3.8
4.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
77
1.57
0.69
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
77
1.57
0.69
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
27
1.86
0.68
5.0
3.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
130
1449
0.88
0.68
1.2
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
11
168
0.65
0.68
2.2
1.6
e6/l
11615.0
17594.8
0.51
11
123
(3009261) Glucose [Presence] in Urine by Test strip
316
2974
1.10
0.67
5.0
4.1
estimate
0.0
0.0
0.00
43
539
(3013512) EKG study
185
2015
0.89
0.67
4.3
4.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
39
482
0.80
0.66
3.7
3.9
%
0.2
0.1
0.28
11
151
(3000330) Specific gravity of Urine by Test strip
30
383
0.78
0.66
5.1
4.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
155
0.64
0.66
1.3
2.1
%
94.7
86.1
—
10
146
(3028300) Cannabinoids [Presence] in Urine
10
62
1.62
0.65
2.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
62
1.62
0.65
2.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
37
458
0.80
0.64
3.8
3.8
%
0.7
0.4
—
9
124
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
95
1.48
0.64
1.9
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
142
1566
0.89
0.63
4.5
3.9
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
87
1.50
0.63
2.4
2.3
—
752.5
—
0
11
(3023103) Potassium [Moles/volume] in Serum or Plasma
599
6150
0.90
0.63
25.7
21.3
mmol/l
4.0
4.0
6.26
582
5972
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
71
1.56
0.62
1.2
1.3
u/ml
100.8
110.3
—
6
10
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
49
1.64
0.62
1.3
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
49
1.64
0.62
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
43
353
1.23
0.61
3.2
4.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
255
0.74
0.60
3.2
2.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
21
0.00
0.60
0.0
4.0
—
49.7
—
0
21
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
373
1.22
0.59
1.3
1.7
g/l
1.7
1.6
0.28
34
321
(1002224) Polysomnography panel
10
150
0.66
0.58
1.1
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
89
1.47
0.58
1.3
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
599
6140
0.91
0.57
25.7
21.2
mmol/l
139.6
139.6
0.05
582
5967
(3014051) Protein [Presence] in Urine by Test strip
10
149
0.67
0.57
4.6
2.4
—
—
—
0
0
(4034850)
14
195
0.71
0.56
7.3
12.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
295
2790
1.09
0.56
5.1
5.4
%
2.7
2.8
0.52
262
2570
(3018010) Neutrophils/100 leukocytes in Blood
295
2791
1.09
0.55
5.3
5.4
%
60.7
58.7
2.11
261
2584
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
123
0.65
0.55
1.1
1.2
u/l
49.7
54.6
—
8
107
(3019069) Monocytes/100 leukocytes in Blood
296
2802
1.09
0.55
5.3
5.7
%
8.7
9.0
0.75
263
2591
(3018095) Leukocytes [#/volume] in Urine
254
2389
1.09
0.54
4.7
3.9
e6/l
66.0
137.0
1.35
187
1786
(3000494) Fungus identified in Specimen by Culture
80
706
1.15
0.53
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
62
1.46
0.53
2.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
62
1.46
0.53
2.6
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
48
564
0.84
0.52
3.6
3.9
mmol/l
1.2
1.2
0.85
39
491
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
152
1.32
0.52
1.4
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
55
473
1.17
0.51
5.4
7.2
mmol/l
25.5
24.3
1.78
50
444
(1616796) Gas panel - Central venous blood
21
162
1.30
0.50
5.0
3.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
52
602
0.85
0.49
1.3
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
49
568
0.85
0.47
1.9
2.1
ug/g
343.4
154.5
0.72
36
449
(4035726)
49
567
0.86
0.46
1.2
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
31
255
1.22
0.46
1.7
2.7
g/l
1.4
1.4
0.00
24
218
(3023419) Bacteria identified in Sputum by Culture
13
94
1.39
0.46
3.1
2.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
49
1.43
0.46
1.0
1.1
—
120.0
—
0
6
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
83
0.60
0.46
4.4
3.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
95
859
1.12
0.45
3.8
7.7
kpa
5.1
5.1
0.14
90
820
(3027801) Oxygen [Partial pressure] in Arterial blood
95
860
1.12
0.44
3.8
7.7
kpa
11.4
11.6
0.15
88
821
(40768797) Stomach Pathology biopsy report
89
803
1.12
0.44
1.4
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
298
2845
1.07
0.44
5.3
5.7
%
24.2
25.8
1.98
262
2614
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
354
3401
1.07
0.44
4.5
6.3
umol/l
11.6
12.3
0.79
322
3231
(3030981) Hyaline casts [#/volume] in Urine by Automated count
34
403
0.84
0.43
3.2
2.9
e6/l
0.1
0.4
3.44
34
391
(4211845)
5
31
1.62
0.43
5.0
3.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
198
1863
1.08
0.42
2.8
3.3
u/l
30.9
36.1
1.63
183
1774
(3022806) Fractional oxyhemoglobin in Capillary blood
6
91
0.66
0.42
1.7
1.9
%
90.5
89.5
—
6
91
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
92
0.65
0.42
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
540
5268
1.07
0.42
5.1
4.6
mu/l
1.9
2.3
0.91
478
4668
(3029937) Albumin [Presence] in Urine by Test strip
173
1620
1.09
0.42
5.9
4.3
estimate
0.0
0.0
0.50
39
518
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
58
1.38
0.41
1.1
1.2
nmol/l
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.0
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.4
—
2.1
—
0
8
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.0
—
1.4
—
0
9
(3000991) Gas panel - Venous blood
69
616
1.13
0.41
3.6
8.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
16
0.00
0.41
0.0
1.6
—
1.2
—
0
16
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.0
—
1.5
—
0
10
(3034988) Calcium [Moles/volume] in Capillary blood
0
16
0.00
0.41
0.0
1.5
—
1.2
—
0
16
(40768443) Skin Pathology biopsy report
24
293
0.81
0.41
1.3
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
205
0.78
0.40
1.4
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
306
2932
1.07
0.40
6.5
5.5
estimate
0.0
0.0
0.00
44
551
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
45
390
1.16
0.40
2.7
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
389
0.84
0.40
4.5
11.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.3
1.5
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
18
0.00
0.40
0.0
1.5
—
4.9
—
0
10
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
35
1.43
0.39
7.6
4.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
35
1.43
0.39
1.6
2.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
3.6
—
22.0
—
0
10
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
137
0.73
0.39
1.8
1.2
—
2.9
—
0
14
(3050129) First trimester maternal screen panel - Serum or Plasma
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
124
1.30
0.39
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
68
1.33
0.37
1.9
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
114
0.70
0.37
1.4
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
216
1.21
0.37
3.3
3.3
nmol/l
0.7
0.9
1.17
19
171
(3026782) Osmolality of Urine
155
1454
1.08
0.37
3.4
2.9
mosm/kgh2o
564.6
551.8
0.32
130
1237
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
29
244
1.20
0.37
1.8
2.4
g/l
36.6
36.9
0.07
21
205
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
180
1.23
0.36
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
45
511
0.87
0.35
5.9
4.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
123
0.73
0.35
1.6
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
150
1595
0.93
0.35
2.3
2.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
181
1.22
0.34
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
94
865
1.10
0.34
3.9
7.7
mmol/l
1.4
1.3
0.02
77
663
(3037756) Immunofixation for Serum or Plasma
13
166
0.78
0.33
1.2
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
182
1.21
0.33
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
86
0.70
0.33
1.5
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
88
0.68
0.33
1.8
4.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
229
1.19
0.32
1.1
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
358
3469
1.06
0.32
6.6
8.5
e9/l
4.7
4.3
1.40
303
2993
(4146454)
10
74
1.36
0.32
3.0
2.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
456
4449
1.06
0.32
4.2
4.1
mm/h
12.9
14.6
1.55
402
4048
(3012441) Differential panel - Pleural fluid
7
98
0.71
0.31
1.9
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
157
1.22
0.29
2.1
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.1
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
109
0.73
0.29
1.8
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
451
4610
0.95
0.28
28.7
23.4
g/l
331.7
331.3
0.44
438
4570
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
729
0.91
0.28
2.6
2.9
umol/l
7.6
9.8
0.83
57
655
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
86
1.28
0.26
1.2
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
522
1.10
0.25
3.4
3.7
ng/l
103.1
93.3
0.31
50
453
(3022621) pH of Urine by Test strip
48
436
1.11
0.24
4.7
3.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
16
191
0.83
0.24
2.8
3.4
mmol/l
1.4
1.6
0.80
16
186
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
77
1.17
0.24
1.7
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
78
1.29
0.24
2.2
2.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
169
1619
1.06
0.23
4.0
4.1
%
83.6
83.6
0.01
162
1582
(3003327) Ova and parasites identified in Stool by Light microscopy
12
147
0.81
0.23
1.7
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
159
1521
1.06
0.23
3.1
2.6
e6/l
5.3
5.2
0.05
139
1345
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.4
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
92
0.76
0.22
1.9
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
9.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
12
0.00
0.21
0.0
1.4
—
7.5
—
0
6
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
9.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
102
0.78
0.21
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
9.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
13
0.00
0.21
0.0
2.3
—
153.9
—
0
13
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
145
1.18
0.20
3.5
2.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
80
850
0.93
0.20
1.9
3.8
u/l
225.9
259.9
1.84
68
792
(3002173) Hemoglobin [Mass/volume] in Arterial blood
74
694
1.07
0.20
3.7
8.8
g/l
123.3
119.6
0.86
68
672
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.0
—
17.6
—
0
9
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
108
1.21
0.20
2.4
2.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
32
353
0.90
0.19
2.2
3.0
—
—
—
0
0
(4024509)
6
53
1.13
0.18
1.7
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
109
1.20
0.18
1.6
1.5
iu/l
3.4
6.4
—
7
32
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
63
591
1.07
0.18
2.1
2.4
u/l
32.1
33.9
0.12
50
504
(3044927) Protein electrophoresis panel - Urine
11
91
1.21
0.17
1.1
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
14
163
0.86
0.17
1.2
2.3
g/l
3.7
3.8
0.12
14
152
(3000093) Morphology [Interpretation] in Blood Narrative
7
63
1.11
0.17
1.1
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
63
1.11
0.17
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
204
2099
0.96
0.17
2.2
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
233
2270
1.04
0.16
5.6
4.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
120
0.83
0.16
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
8
72
1.11
0.16
1.0
1.2
—
251.1
—
0
27
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
79
1.14
0.15
5.8
3.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
79
1.14
0.15
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
327
0.91
0.15
1.3
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
112
1.16
0.14
1.9
3.0
e9/l
4.0
4.7
0.73
13
112
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
257
1.09
0.13
1.1
1.1
iu/ml
278.6
173.5
0.41
12
87
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
180
0.89
0.13
2.3
2.4
ug/min
290.3
102.1
—
6
103
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
110
0.82
0.13
1.8
1.2
—
3.1
—
0
8
(3022948) Iron [Moles/volume] in Serum or Plasma
120
1162
1.04
0.12
1.9
2.5
umol/l
11.4
12.0
0.50
108
1073
(3004119) Hemoglobin [Mass/volume] in Venous blood
44
466
0.94
0.11
3.2
3.2
g/l
130.5
125.7
0.78
44
456
(1761482) Bacteria [#/volume] in Urine by Culture
21
229
0.91
0.11
4.8
5.4
—
—
—
0
0
(3010421) pH of Blood
18
198
0.91
0.10
7.2
4.4
ph
7.4
7.4
0.29
13
163
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
52
495
1.05
0.10
2.6
3.2
ml/min/173m2
69.1
58.0
0.76
22
217
(3023420) DNA double strand Ab [Units/volume] in Serum
5
44
1.14
0.10
2.2
1.4
—
38.4
—
0
5
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
44
1.14
0.10
1.2
1.2
—
71.5
—
0
6
(3044242) Glucose [Moles/volume] in Arterial blood
5
46
1.09
0.09
1.6
3.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
47
1.06
0.09
1.4
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
98
1009
0.97
0.09
2.0
2.5
%
20.6
21.7
0.48
78
860
(3051651) Icteric interference index of Serum or Plasma
5
48
1.04
0.09
8.8
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
34
321
1.06
0.09
1.4
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
56
1.07
0.08
1.2
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
63
0.79
0.08
1.2
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
117
1.11
0.08
2.0
3.3
%
58.1
60.3
0.27
13
117
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
70
723
0.97
0.08
4.5
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
297
0.94
0.08
1.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
127
1.10
0.08
2.3
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
68
1.03
0.08
1.3
2.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
68
1.03
0.08
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
499
0.96
0.07
1.4
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
112
0.89
0.07
1.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
118
1.10
0.07
2.2
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
206
1.07
0.07
1.6
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
122
0.90
0.07
1.9
1.8
nmol/l
49.5
44.1
0.27
11
114
(3042631) Mycobacterium sp identified in Specimen
9
103
0.87
0.06
5.7
3.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
26
247
1.05
0.05
2.1
2.9
g/l
0.2
0.3
—
9
97
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
587
5846
1.01
0.05
22.1
17.7
mg/l
27.5
28.0
0.12
515
4793
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
41
398
1.03
0.04
3.7
9.8
mmol/l
25.0
24.7
0.21
36
370
(3042936) Bacteria identified in Isolate by Culture
101
1024
0.98
0.03
1.9
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
499
5008
0.99
0.03
22.5
19.2
%
37.1
38.5
1.57
277
3142
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
270
1.04
0.03
3.3
2.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
253
2514
1.01
0.03
2.5
2.7
ug/l
146.5
156.7
0.24
228
2248
(40760888) Immunoglobulin light chains.free panel - Serum
16
168
0.95
0.02
1.1
3.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
93
1.08
0.02
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
93
1.08
0.02
1.5
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
197
0.96
0.01
1.4
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
105
1058
0.99
0.01
1.9
2.5
g/l
2.2
2.3
0.59
96
974
(3017732) Neutrophils [#/volume] in Blood
39
383
1.02
0.01
2.4
2.9
e9/l
3.7
4.1
0.59
26
273
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
96
1.04
0.00
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
225
1.02
0.00
1.6
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
113
0.97
0.00
2.2
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
466
1.01
0.00
1.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
66
657
1.00
0.00
1.5
1.3
titre
390.0
433.8
0.17
20
149
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
111
0.99
0.00
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
129
1287
1.00
0.00
1.4
1.6
mg/l
1.7
1.4
0.36
103
1016
(3024928) Oxygen saturation in Venous blood
16
161
0.99
0.00
1.9
2.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
802
1.00
0.00
3.9
4.7
%
36.8
32.7
2.05
54
509
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
109.8
—
0
6
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
52
0.96
0.00
1.0
1.5
—
412.9
—
0
7
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
5.6
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
90
1.00
0.00
1.7
1.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.1
—
21.0
—
0
9
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
103.0
—
0
9
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
54
0.93
0.00
1.2
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
11.4
—
6.8
—
0
7
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
2.0
1.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
3.2
1.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
49
1.02
0.00
1.0
1.4
—
55.0
—
0
8
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
90.3
—
0
8
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
2.0
—
0.6
—
0
7
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
36
360
1.00
0.00
3.4
3.9
%
45.9
47.2
0.12
36
355
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
7.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
60
1.00
0.00
1.3
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
53
0.94
0.00
1.2
1.5
—
18.8
—
0
11
(3045424) Erythrocytes [Presence] in Urine
8
89
0.90
0.00
1.6
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
63
0.95
0.00
1.0
3.4
nmol/l
3.7
6.1
—
6
63
Mortality – FinRegistry
↥Association
Association between endpoint G6_DEGENOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_DEGENOTH | 3.447 [3.0, 3.96] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.576 |
During the follow-up period (1.1.1998 — 31.12.2019), 2005 out of 3191 females with G6_DEGENOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_DEGENOTH | 3.577 [3.04, 4.2] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 2129 out of 3230 males with G6_DEGENOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_DEGENOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.489% | 0.688% |
| 5 | 2.564% | 3.686% |
| 10 | 5.012% | 9.047% |
| 15 | 9.392% | 16.18% |
| 20 | 16.978% | 26.346% |
Relationships between endpoints
↥Index endpoint: G6_DEGENOTH – Other and unspecified degenerative diseases of nervous system
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data